Status: Recruiting
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC
This is an open-label, single arm Phase II study designed to evaluate the efficacy and safety of adebelizumab combined with carboplatin/Cisplatin plus (+) etoposide and concurrent radiotherapy in the first-line treatment of patients with extensive stage oligometastatic small cell lung cancer.
Participants needed: 62
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Nanfang Hospital, Southern Medical UniversityUpdated: Dec 20, 2023Locations: 1
Eligibility criteria
Signed inform consent form [+6]
Spinal cord compression not definitively treated with surgery and/or radiation o... [+12]